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Abstract
Onychomycosis is a very common condition that accounts for 50% of all nail pathologies. Currently 2–5% of the
world population suffers from this disorder. It is primarily caused by dermatophytes, but the infection can also be
caused by yeasts and non-dermatophyte moulds. Onychomycosis is a therapeutic challenge and recently there has
been an increase in resistance to oral and topical antifungal agents, leading to 20–25% relapse and/or reinfection
rate. During the past 5 years, the emergence of laser therapy has been the topic of discussion as a newer, safer
modality of treatment.
Nail clippings and scrapings are the most common methods of sampling for suspected onychomycosis. The
simplest method for detecting fungi is by way of 20% potassium hydroxide (KOH) preparations, but lately show
insufficient sensitivity in onychomycosis – as much as 40–68%. Fungi can also be grown in culture form; however a
70% sensitivity detection failure rate is seen. Recently, histological fungal detection – in the form of Periodic Acid-
Schiff (PAS) stain – has shown high sensitivity at 92% in the detection of fungal elements.
The exact mechanism of action of laser is unknown but it is believed that heat disintegrates fungal structures.
One of the most appealing characteristics of laser therapy is its ability to deliver energy to the target tissue and avoid
systemic side effects at the same time. In 2009 the United Kingdom (UK) Podiatry magazine Podiatry Now published
a letter suggesting laser treatment was “possibly the most radical development in the treatment of onychomycosis
our profession has ever seen”, although concerns were raised over the unproven efficacy and investment costs
involved.
Papers have been published investigating the efficacy of lasers for the treatment of onychomycosis. Even though
laser therapy provides an alternative option with rapid procedure duration, conflicting evidence is shown in a variety
of papers and studies with longer follow-up periods suggest onychomycosis relapse in those treated with laser,
which warrants further investigation.
Keywords: Onychomycosis; Resistance; Laser; New treatment; 1064
nm wavelength; Heat; Effectiveness; Review
Abbreviations: KOH: Potassium Hydroxide; PAS stain: Periodic
Acid-Schiff Stain; ATP: Adenosine Triphosphate; UK: United Kingdom
Introduction
Onychomycosis, a chronic, specific fungal infection of the toenail, is
a very common condition that accounts for 50% of all nail pathologies
[1-7]. Currently 2–5% of the world population suffer from this
disorder [8,9]. It is primarily caused by dermatophytes, but the
infection can also be caused by yeasts and non-dermatophyte moulds
[5,7,10-13]. Onychomycosis is a therapeutic challenge and recently
there has been an increase in resistance to oral and topical antifungal
agents, leading to 20–25% relapse and/or reinfection rate
[2-4,6,9,10,14-17]. During the past 5 years, the emergence of laser
therapy has been the topic of discussion as a newer, safer modality of
treatment [2-4,8,9,14,18-20]. Although new research using
phototherapy for onychomycosis shows promising short term results,
these studies have a very small output and are poorly designed [14,19].
Method
This paper will describe the various types of onychomycosis, its
causative organisms, types of microscopic investigations done and
current treatment modalities used according to literature. The author
will also discuss whether laser therapy is the new best evidence based
treatment for onychomycosis or not.
Discussion
Although onychomycosis is not life-threatening, most patients seek
treatment for cosmetic reasons or pain relief [4,19,21].
Causes of Onychomycosis
Dermatomycoses (sub-division: onychomycosis) is mainly caused
by dermatophytes, yeasts and non-dermatophyte moulds
[5,7,10-12,15,21].
The most common fungal agent that causes this condition is
dermatophytes, which accounts for 60–80% of infections [5]. This is
followed by yeasts and lastly (rarely) non-dermatophyte moulds [21].
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Dermatophytes
Trichophyton rubrum
Trichophyton rubrum continues to be the most isolated causative
pathogen for onychomycosis in the world [5,7,10-12,15,21].
In the Greek language Trichophyton means “plant” and “hair”,
whilst rubrum denotes “red” [12].
This dermatophyte mainly targets nail keratin (Figure 1) [12].
Figure 1: Trichophyton rubrum on Sabouraud’s dextrose agar [12].
Trichophyton interdigitale
Trichophyton interdigitale (previously known as Trichophyton
mentagrophytes) is the second most prevalent causative dermatophyte
pathogen [5,7,12,21].
This infection originally starts in between the toes and later spreads
to the nail (Figure 2) [12,21].
Figure 2: Trichophyton interdigitale on Sabouraud’s dextrose agar
[12].
Epidermophyton floccosum
As with Trichophyton interdigitale, this infection starts on the skin
and later spreads to the nails.
It is an ananthropophilic species that is a common cause of tinea
pedis (athlete’s foot) (Figure 3) [12,21].
 
Figure 3: Epidermophyton floccosum on Sabouraud’s dextrose agar
[12].
Although these dermatophytes are not exclusively the causative
agents for onychomycosis, they are considered the most common
[5,7,10-12,15,21].
Home Transmission and Virulence Factors of
Dermatophytes
Onychomycosis transmission between family members most
commonly occur via the bath [11,12].
The spread of onychomycosis is classified into two groups:
horizontal spread between spouses and vertical spread between family
members (most common) [12]. Virulence factors must be present for
infection to occur [12,21].
Hair, skin and nail cytokeratin is the dermatophytes target structure
for infection and degradation takes place through keratinase –
targeting the structure’s complex proteins. Enzyme activity at normal
body temperature and pH of the host skin creates a reservoir for the
organism.
This means that the strain is only found on the person or in his
home. Infection spread pathways are either direct (contact from one
person to another – less common) or indirect (walking barefoot on
contaminated surfaces – more common) [11].
Onychomycosis due to Yeasts and Non-Dermatophyte
Moulds
Reports show an increase in onychomycosis caused by yeasts and
non-dermatophyte moulds [12].
The most noticeable among these are Candida albicans, Candida
parapsilosis, Candida glabrata, Candida krusei and Aspergillus
fumigates [5,10,12,21].
Most often these moulds grow saprophytically due to contamination
on nails with pathological changes, e.g. Psoriasis (Tables 1 and 2) [12].
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CLASSIFICATION CLINICAL APPEARANCE DESCRIPTION
Distal subungal onychomycosis (DSO) Distal free edge of nail
Hyperkeratotic
Brownish-yellow
Lateral and distolateral subungal
onychomycosis (DLSO)
Continuation from DSO
Pathogen migrates from hyponychium at side proximally
Hyperkeratotic
Brownish-yellow
Proximal subungal onychomycosis (PSO) Rare
Spreads from cuticle to eponychium in immunosuppressed patients
Hyperkeratotic
Brownish-yellow
White superficial onychomycosis (WSO) Superficial nail plate infection
White plaque-like layer covers the nail plate
Proximal white subungal onychomycosis
(PWSO)
Special variant
White discolouration underneath proximal part of nail plate
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Total dystrophic onychomycosis (TDO) “Glacier nail”
Longitudinal yellow streaks stretching medially and laterally reaching the nail matrix
Table 1: Classification, clinical appearance and description of different types of onychomycosis [12,21].
Predisposing factors
Diabetes Mellitus
Peripheral vascular arterial disease
Chronic venous insufficiency
Polyneuropathies
Immunosuppression
Microtrauma (in athletes)
Hyperhidrosis
Lymphoedema
Malalignment of the feet
Psoriasis
Ichthyosis vulgaris
Table 2: Most common predisposing factors for onychomycosis [5,14].
Impaired Quality of Life and Stigmatisation due to
Onychomycosis
Studies have found that generally patients with onychomycosis
avoid social gatherings as they have a fear of transmitting the infection
to other people [5,11,12].
When patients were asked how they feel about the stigma
onychomycosis has caused, patients felt greatest impairment due to
onychomycosis being contagious; felt other people would stare at their
nails and felt unattractive [5,12]. The most common problems affecting
patient quality of life is cutting nails; disfigurement (cosmetically); ill-
fitting shoes, leading to pain and discomfort [5,12].
Diagnostic Sampling and Microscopic Preparations
Nail clippings and scrapings are the most common methods of
sampling for suspected onychomycosis [10-12]. Research shows
different microorganism detection techniques with varying sensitivity
and specificity rates [5,13,21]. The simplest method for detecting fungi
is by way of 20% potassium hydroxide (KOH) preparations [5,21]. Nail
scrapings are taken from the infected site and mounted on a glass slide
with a 20% KOH solution.
The solution is then heated to a point where the epidermal cell
keratin is dissolved and the fungal elements are left. The preparation is
then examined microscopically for hyphae, budding cells or spores
[22]. Unfortunately the conventional KOH preparations lately show
insufficient sensitivity in onychomycosis – as much as 40–68% [21].
Fungi can also be grown in culture form, using Sabouraud 2%
dextrose agar, however a 70% sensitivity detection failure rate is seen,
possibly due to pre-treatment with oral or topical antifungal agents
[7,13]. As a result, fungi are already inhibited in vivo, preventing
growth in vitro [5,21]. The presence of non-dermatophytes in the
culture specimens can further confound the identification of the causal
organism [22]. Recently, histological fungal detection – in the form of
Periodic Acid-Schiff (PAS) stain – has shown high sensitivity at 92% in
the detection of fungal elements [13,14,21]. In this method the fungal
wall glycoprotein, basement membrane material and mucosubstances
are stained bright red, whilst other background elements are stained
pink-blue [22,23]. However, specificity is low as there is no indication
of fungal genus of species [21]. When it comes to histological PAS
staining, it is imperative that nail evaluations be done by a
histopathologist, so as to avoid incorrect diagnoses, e.g. nail dystrophy,
Psoriasis, etc. [14,21,23].
Current Treatment Modalities for Onychomycosis
Oral antifungal agents (terbinafine hydrochloride, itraconazole and
fluconazole) are the medications of choice for this condition, as either
continuous or “pulse” therapies [7,10,13]. Terbinafine hydrochloride is
still considered the gold standard first-line treatment. However, it is
contraindicated in certain patient groups, including those with any
variant of liver impairment or disease [24].
Recently there has been an increase in resistance shown to these
medications – oral terbinafine hydrochloride with an efficacy of 35–
78% and itraconazole being even less effective [24,25] and various
questions remain as to their safety for patients and their potential to
cause hepatotoxicity and drug interactions [3,4,9,10,15-17,22,24,25].
Topical antifungal treatments in the form of nail lacquers
(amorolfine and ciclosporox) are preferred by most patients as they
have less serious side effects.
These agents can only be administered to those who have
onychomycosis without matrix involvement and requires extensive
patient monitoring, as lacquers need to be applied weekly for a period
between nine to twelve months [9,22,24].
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Serious questions also arise on the effectiveness of nail penetration
as well as issues relating to increased organism resistance [1,9,10,15].
Despite diligent patient application, ciclosporox is only effective in
about 10% of patients [24].
New Emerging Laser Therapy for the Treatment of
Onychomycosis
Limitations in outcomes of both oral and topical antifungal agents
have led to the investigation of laser and light as a possible new way of
treating onychomycosis [3,8,18].
This new treatment modality has only been in the spotlight since
2010, although scientists have been looking into laser therapy as early
as 1980 [14].
Mechanism of Action
Laser is an acronym for “light amplification by stimulated emission
of radiation”. They can be spot focused while maintaining a very high
radiance [22].
The exact mechanism of action of laser is unknown but it is believed
that heat disintegrates fungal structures. Studies show lasers of near-
infrared light range with wavelengths of 780–3000 nm being used, but
most commonly the Nd: YAG 1064 nm laser [8,13].
The 1064 nm wavelength has the ability to pass into the nail bed.
Consequently, any fungal material in the nail bed is heated to
extremely high temperatures which inhibits growth, causes damage
and targets cells. With the high temperatures, toxic levels of adenosine
triphosphate (ATP) and oxygen are created, disrupting fungal
mitochondrial membrane potential, leading to slower growth rates and
eventually growth completely stops [8,13,14,25].
It is also suggested that the 1064 nm might be useful in targeting the
blood supply associated with fungal viability as this wavelength is
readily absorbed by Haemoglobin [25].
However, heat should exceed 45°C as normal body temperature
(37°C) is the optimal growth temperature for fungi [8,13,14].
Clinical Method of Laser Application
After establishing microscopic evidence of onychomycosis, photos
of infected nails are taken to determine new nail regrowth after an
extended period of time – usually between two and 16 weeks [2,8,25].
All patients receiving laser therapy undergo routine general
podiatric care (thinning of hypertrophic and onycholytic nail plate to
the thickness of 1-3 mm) prior to the procedure. No intravenous or
topical anaesthetic is given [25].
Spot diameters, energy fluence and exposure time all vary, but are
applied in a criss-cross pattern (vertically and horizontally) with two
alternating passes of laser pulses to cover the full nail surface
[2,3,4,8,13,25].
Nail plate temperature may be taken immediately after the
procedure to establish efficacy of treatment [8]. No home treatment is
required by the patient after the laser procedure, however more than
one treatment may be necessary (Figure 4) [3,8,25].
Figure 4: Patient X’s nail prior and post 9 months treatment [25].
Review of Lasers for the Treatment of Onychomycosis:
Evidence Based or Not?
One of the most appealing characteristics of laser therapy is its
ability to deliver energy to the target tissue and avoid systemic side
effects at the same time [24]. In 2009 the United Kingdom (UK)
Podiatry magazine Podiatry Now published a letter suggesting laser
treatment was “possibly the most radical development in the treatment
of onychomycosis our profession has ever seen”, although concerns
were raised over the unproven efficacy and investment costs involved
[14]. Recently preliminary studies show good clinical and
microscopical cure rates using the 1064 nm laser in the short term
[2,4,11,18,20].
In Vitro Studies
One study achieved 100% inactivation of Trichophyton rubrum in
vitro 91 h after treatment with an 870/930 nm dual wavelength laser,
using a 1.5 cm diameter flat-top projection with a power density of
5.66 W cm-2. The same projections were used on Candida albicans at
physiologic temperatures and these fungi were completely inactivated
at just 20 h. Notably an increase in reactive oxygen species and a
decrease in transmembrane potentials of fungi were measured using
non-lethal dosimetry. Afterward, human pilot studies were performed
and no damage to nail matrix was observed [26]. Another study
conducted by Manevitch et al. took nail clippings infected with
Trichophyton rubrum and irradiated it with an 870 nm infrared
titanium sapphire laser. Intensities of 7 × 1031 photons/m2s were used
and as a result negative cultures were produced 4 weeks post-
irradiation [24].
Vural et al. treated Trichophyton rubrum colonies with various
lasers ranging from 585 nm pulsed dye to 2940 nm Er: YAG and
discovered that they did not inhibit fungal growth, however, colonies
treated with Q-switched 532 nm and 1064 nm Nd: YAG lasers had a
significantly lower growth rate [27]. They noted that the efficacy of the
532 nm wavelength may be related to the absorption of the red
pigment xanthomegnin, which is present in Trichophyton rubrum (red
hairy plant) (Table 3) [27].
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AUTHORS ORGANISM LASER POWER DENSITY OUTCOMES
Bornstein et al. Trichophyton rubrum 870/930 nm dual wavelength 5, 66 W cm-2 100% inactivation after 91 h
Candida albicans 870/930 nm dual wavelength 5, 66 W cm-2 100% inactivation after 20 h
Becker and Bershow Trichophyton rubrum 870 nm infrared titanium
sapphire
7 × 1031 photons/m2s Negative culture 4 weeks post
irradiation
Vural et al. Trichophyton rubrum 585 nm pulsed dye to 2940 nm
Er: YAG
--- Did not inhibit fungal growth
Trichophyton rubrum Q-switched 532 nm and 1064
nm Nd: YAG
--- Colonies had significantly lower growth
rates
Table 3: Summary of results obtained for in vitro studies [24,26,27].
In Vivo Studies
Horine et al. yielded retrospective results from an international
multicentre study of 262 patients. Patients received one PinPointe
short-pulsed Nd: YAG 1064 nm laser treatment. A single spot
consisted of a pulse train of ten 200 mJ, 90 µs duration pulses at 1064
nm, delivered into a 1.5 mm spot. Laser was delivered in a 1.0-1.5 mm
spacing grid pattern. The average light dose per nail plate was 115 J/
cm2. One or two laser passes was delivered per infected nail. Pre-
treatment debridement and thinning of onycholytic hyperkeratotic nail
plate to 1 mm was achieved using a high-speed burr. Photographs were
taken of the hallux at baseline and at post-procedure follow-up. A
100% response rate was seen with a mean of 78% absolute clear nail
was achieved at seven month post-procedure follow-up [25].
Becker and Bershow reviewed three studies which achieved clinical
success using a 1064 nm Nd: YAG laser. One study 72 patients received
four laser treatments with one week between sessions. Three months
post-treatment, 95.8% were clinically clear and culture negative. No
details on culture sampling or laser parameters was given. All patients
were followed up 6, 9 and 12 months post-procedure for recurrence
and at the end of the study all patients were clinically and culture
negative. In the second study eight patients were treated every three
weeks for three sessions with a 1064 nm pulsed Nd: YAG laser. Seven
out of eight patients were culture negative after the third treatment. No
significant side effects were reported. These patients were also
prescribed a topical nail lacquer after the first laser treatment. A third
study conducted by Kimura et al. irradiated 37 toenails with
microscopically confirmed onychomycosis up to three times with a
1064 nm Nd: YAG laser. At 16 weeks post-procedure follow-up 81% of
toenails exhibited moderate to complete clearance [2,24].In 2014,
Birstow did a systematic review of the effectiveness of lasers in the
treatment of onychomycosis. Any original study, published in a peer
reviewed journal, which examined the use of a laser technology in the
treatment of onychomycosis was considered for inclusion. The initial
search yielded 268 potential papers. Subsequently, duplicate papers,
papers that did not fit the inclusion criteria and papers whose full
study details were not obtainable were excluded from the review.
The remaining 12 papers that were published in the last four years
were included in the review. He concluded that to date the data
reported was at a low level of evidence as it was made up
predominantly of case series involving a small number of patients with
only two small randomised controlled studies (Table 4) [14].
AUTHORS LASER PATIENTS/NAILS TREATMENT DURATION OUTCOMES
Horine et al. PinPointe short-pulsed
1064 nm Nd: YAG
262 patients One treatment per infected nail 100% response rate; mean of 78% absolute
clear nail at 7/12 follow up
Becker and Bershow 1064 nm Nd: YAG 72 patients Four treatments; one week
between sessions
95, 8% clinically clear and culture negative at
3/12 follow up
1064 nm Nd: YAG 8 patients Every three weeks for three
sessions (3; 6; 9)
Seven out of eight patients culture negative
after third treatment
Note: Topical antifungal prescribed after first
treatment
1064 nm Nd: YAG 37 toenails Up to three treatments 16 weeks follow up 81% exhibited moderate to
complete clearance
Birstow Noveon continuous wave
830 nm/930 nm
37 toenails (26 treated; 11
control)
One treatment per infected nail 6/12 follow up;
Complete clearance/markedly improved: 2
treated nails vs. 2 controls
Slight/moderate improvement: 18 treated nails
vs. 3 control
Unchanged: 6 treated nails vs. 6 control
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Q-clear Q-switched 1064
nm/532 nm Nd: YAG
131 patients Two treatments 30 days apart 2/12 follow up microscopy and culture cure
rate of 95, 4%
1064 nm Nd: YAG short
pulse vs. long pulse
10 patients Two treatments four weeks apart 9/12 follow up microscopy and culture cure
rate of 65%
Only 4 cases visibly improved (photo evidence)
Table 4: Summary of results obtained for In Vivo studies [14,24,25].
Conclusion
In the last five years, papers have been published investigating the
efficacy of lasers for the treatment of onychomycosis.
Even though laser therapy provides an alternative option with rapid
procedure duration, virtually no side effects, no blood monitoring and
few contraindications, conflicting evidence is shown in a variety of
papers, study designs are poor with small study samples, limited
output with no clear protocol and studies with longer follow-up
periods suggest onychomycosis relapse in those treated with laser,
which warrants further investigation.
To date, oral terbinafine hydrochloride has a high cure rate five
years post-treatment at 46% and is still considered the most effective,
proven, long-term treatment for onychomycosis in patients without
contraindications to oral antifungal therapy.
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